Related references
Note: Only part of the references are listed.Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells
Chenxi Hu et al.
ONCOTARGETS AND THERAPY (2019)
Tumor Vasculatures: A New Target for Cancer Immunotherapy
Zhigang Liu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
Jianming Xu et al.
CLINICAL CANCER RESEARCH (2019)
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
Chiao-Ling Tsai et al.
HEPATOLOGY (2018)
Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors
Xiao Wei et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer
Xi Cheng et al.
CANCER LETTERS (2018)
The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study
Yoshiyuki Wada et al.
INTERNAL MEDICINE (2018)
Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study
Wen-Chang Yu et al.
MEDICINE (2018)
Cancer Radiosensitizers
Hao Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial
Sang Min Yoon et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
Chun-Yan Lan et al.
LANCET ONCOLOGY (2018)
The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study
Liu Zhen et al.
JOURNAL OF CANCER (2018)
Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma
Chaoxu Yang et al.
CANCER MEDICINE (2018)
Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer
Haoran Feng et al.
CELL DEATH & DISEASE (2018)
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma\
Anne Clavreul et al.
DRUG DELIVERY (2018)
RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
Mariam Gachechiladze et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC Case report
Chunbo Zhao et al.
MEDICINE (2017)
Recent Developments in Radiotherapy
Deborah E. Citrin
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
Kuisheng Liu et al.
CELL DEATH & DISEASE (2017)
Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial
Wei Lu et al.
CANCER BIOLOGY & THERAPY (2017)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R. Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study
Nitin Ohri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study
Nitin Ohri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
Katarzyna B. Leszczynska et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretrnted patients with metastatic triple-negative breast cancer
Xichun Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Radiation-induced signaling pathways that promote cancer cell survival (Review)
Ashley L. Hein et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma
Shang-Wen Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo
Wen Yu et al.
CANCER LETTERS (2013)
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
Ann-Lii Cheng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
Alexis Bujold et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs-Dependent DNA Double-Strand Break Repair
Mahmoud Toulany et al.
MOLECULAR CANCER RESEARCH (2012)
Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia
Shingo Matsumoto et al.
CANCER RESEARCH (2011)
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
Shu Tian et al.
CANCER SCIENCE (2011)
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
Sandrine Faivre et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Class IPI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity
Remko Prevo et al.
CANCER RESEARCH (2008)
PKBα/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival
Lana Bozulic et al.
MOLECULAR CELL (2008)
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
Johan Bussink et al.
LANCET ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Share Paper
